90 related articles for article (PubMed ID: 16818283)
1. Size matters: the prognostic implications of large and small deletions of the derivative 9 chromosome in chronic myeloid leukemia.
Fourouclas N; Campbell PJ; Bench AJ; Swanton S; Baxter EJ; Huntly BJ; Green AR
Haematologica; 2006 Jul; 91(7):952-5. PubMed ID: 16818283
[TBL] [Abstract][Full Text] [Related]
2. [The prognostic significance of derivative chromosome 9 deletions in chronic myeloid leukemia].
Wu W; Li JY; Shen YF; Cao XS; Qiu HR; Xu W
Zhonghua Nei Ke Za Zhi; 2007 May; 46(5):386-8. PubMed ID: 17637307
[TBL] [Abstract][Full Text] [Related]
3. The negative prognostic impact of derivative 9 deletions in patients who received hydroxyurea treatment for chronic myelogenous leukemia in the chronic phase.
Li JY; Xu W; Wu W; Zhu Y; Qiu HR; Zhang R; Zhang SJ; Qian SX
Onkologie; 2008 Nov; 31(11):585-9. PubMed ID: 19145090
[TBL] [Abstract][Full Text] [Related]
4. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
5. Deletion size characterization of der(9) deletions in Philadelphia-positive chronic myeloid leukemia.
Douet-Guilbert N; Morel F; Quemener S; Maguer A; Le Bris MJ; Morice P; Berthou C; De Braekeleer M
Cancer Genet Cytogenet; 2006 Oct; 170(2):89-92. PubMed ID: 17011977
[TBL] [Abstract][Full Text] [Related]
6. Deletions on der(9) chromosome in adult Ph-positive acute lymphoblastic leukemia occur with a frequency similar to that observed in chronic myeloid leukemia.
Specchia G; Albano F; Anelli L; Storlazzi CT; Zagaria A; Mancini M; Cuneo A; Pane F; Foà R; Manolelli F; Liso V; Rocchi M
Leukemia; 2003 Mar; 17(3):528-31. PubMed ID: 12646940
[TBL] [Abstract][Full Text] [Related]
7. [Deletions of derivative chromosome 9 in 138 patients with chronic myeloid leukemia].
Wang L; Qian SX; Qiu HR; Wang R; Zhang SJ; Miao KR; Fan L; Xu W; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):281-4. PubMed ID: 19379551
[TBL] [Abstract][Full Text] [Related]
8. [Detection of bcr/abl fusion gene and its derivative chromosome 9 deletions in CML by using home-made bcr/abl extra-signal probe].
Lai YY; Feng L; Wang Z; Lü S; Dang H; Shi Y; He Q; Huang XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):199-203. PubMed ID: 20137147
[TBL] [Abstract][Full Text] [Related]
9. Clinical correlates of submicroscopic deletions involving the ABL-BCR translocation region in chronic myeloid leukemia.
Yoong Y; VanDeWalker TJ; Carlson RO; Dewald GW; Tefferi A
Eur J Haematol; 2005 Feb; 74(2):124-7. PubMed ID: 15654903
[TBL] [Abstract][Full Text] [Related]
10. Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases.
Albano F; Specchia G; Anelli L; Zagaria A; Storlazzi CT; Buquicchio C; Roberti MG; Liso V; Rocchi M
Genes Chromosomes Cancer; 2003 Apr; 36(4):353-60. PubMed ID: 12619159
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of Philadelphia chromosome positive cells with and without der(9) deletion in a patient with chronic myelogenous leukemia.
Xinh PT; Vu HA; Nghia H; Binh NT; Van Be T; Van Binh T; Tokunaga K; Sato Y
Cancer Genet Cytogenet; 2006 Jan; 164(2):122-7. PubMed ID: 16434314
[TBL] [Abstract][Full Text] [Related]
12. Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia.
Huntly BJ; Reid AG; Bench AJ; Campbell LJ; Telford N; Shepherd P; Szer J; Prince HM; Turner P; Grace C; Nacheva EP; Green AR
Blood; 2001 Sep; 98(6):1732-8. PubMed ID: 11535505
[TBL] [Abstract][Full Text] [Related]
13. On the genesis and prognosis of variant translocations in chronic myeloid leukemia.
Gorusu M; Benn P; Li Z; Fang M
Cancer Genet Cytogenet; 2007 Mar; 173(2):97-106. PubMed ID: 17321324
[TBL] [Abstract][Full Text] [Related]
14. Derivative chromosome 9 deletions in chronic myeloid leukemia are associated with loss of tumor suppressor genes.
Specchia G; Albano F; Anelli L; Storlazzi CT; Zagaria A; Liso A; Pannunzio A; Pastore D; Mestice A; Greco G; Liso V; Rocchi M
Leuk Lymphoma; 2004 Apr; 45(4):689-94. PubMed ID: 15160940
[TBL] [Abstract][Full Text] [Related]
15. Heterogenic molecular basis for loss of ABL1-BCR transcription: deletions in der(9)t(9;22) and variants of standard t(9;22) in BCR-ABL1-positive chronic myeloid leukemia.
Loncarevic IF; Römer J; Starke H; Heller A; Bleck C; Ziegler M; Fiedler W; Liehr T; Clement JH; Claussen U
Genes Chromosomes Cancer; 2002 Jun; 34(2):193-200. PubMed ID: 11979553
[TBL] [Abstract][Full Text] [Related]
16. BCR/ABL rearrangement in two cases of Philadelphia chromosome negative chronic myeloid leukemia: deletion on the derivative chromosome 9 may or not be present.
Batista DA; Hawkins A; Murphy KM; Griffin CA
Cancer Genet Cytogenet; 2005 Dec; 163(2):164-7. PubMed ID: 16337861
[TBL] [Abstract][Full Text] [Related]
17. Deletion of any part of the BCR or ABL gene on the derivative chromosome 9 is a poor prognostic marker in chronic myelogenous leukemia.
Lee YK; Kim YR; Min HC; Oh BR; Kim TY; Kim YS; Cho HI; Kim HC; Lee YS; Lee DS
Cancer Genet Cytogenet; 2006 Apr; 166(1):65-73. PubMed ID: 16616113
[TBL] [Abstract][Full Text] [Related]
18. [Study of deletion of derivative chromosome 9 in patients with Ph+ chronic myeloid leukemia].
Wu W; Xue YQ; Wu YF; Pan JL; Shen J
Zhonghua Xue Ye Xue Za Zhi; 2006 Mar; 27(3):183-6. PubMed ID: 16792921
[TBL] [Abstract][Full Text] [Related]
19. No significance of derivative chromosome 9 deletion on the clearance kinetics of BCR/ABL fusion transcripts, cytogenetic or molecular response, loss of response, or treatment failure to imatinib mesylate therapy for chronic myeloid leukemia.
Kim DH; Popradi G; Sriharsha L; Kamel-Reid S; Chang H; Messner HA; Lipton JH
Cancer; 2008 Aug; 113(4):772-81. PubMed ID: 18543309
[TBL] [Abstract][Full Text] [Related]
20. High-resolution analysis of acquired genomic imbalances in bone marrow samples from chronic myeloid leukemia patients by use of multiple short DNA probes.
Reid AG; Tarpey PS; Nacheva EP
Genes Chromosomes Cancer; 2003 Jul; 37(3):282-90. PubMed ID: 12759926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
